Market Closed -
Nasdaq
01:30:00 25/05/2024 am IST
5-day change
1st Jan Change
5.05
USD
-5.25%
+0.40%
+11.73%
Presentation Operator MessageOperator (Operator)Hello, and good morning, everyone. Welcome to ...
This article is reserved for subscribers
Signed up already?
Log In Not subscribed yet?
Subscribe
Earnings Flash (PRPH) PROPHASE LABS Posts Q1 Revenue $3.6M, vs. Street Est of $9.9M
10/05
MT
Transcript : ProPhase Labs, Inc., Q1 2024 Earnings Call, May 09, 2024
09/05
Earnings Flash (PRPH) PROPHASE LABS Posts Q1 Revenue $3.6M
09/05
MT
ProPhase Labs, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
09/05
CI
Health Care Ticks Up After UnitedHealth Earnings -- Health Care Roundup
17/04
DJ
ProPhase Labs, Inc. Unveils Project ZenQ-AI
16/04
CI
Transcript : ProPhase Labs, Inc., 2023 Earnings Call, Mar 15, 2024
15/03
ProPhase Labs, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
15/03
CI
North American Morning Briefing : Inflation -2-
15/03
DJ
Prophase Labs, Inc. Announces Important Developments in the Company?s Efforts to Commercialize Its Novel Be-Smart Esophageal Cancer Diagnostic Test
20/02
CI
ProPhase Labs, Inc. Announces Preliminary Positive Results for Dietary Supplement Equivir
14/02
CI
ProPhase Labs Names Jed Latkin as Chief Operating Officer
04/01
MT
ProPhase Labs, Inc. Appoints Jed Latkin as COO
04/01
CI
Tranche Update on ProPhase Labs, Inc.'s Equity Buyback Plan announced on March 15, 2023.
14/11
CI
HC Wainwright Cuts Price Target on ProPhase Labs to $11 From $14, Maintains Buy Rating
10/11
MT
Transcript : ProPhase Labs, Inc., Q3 2023 Earnings Call, Nov 09, 2023
09/11
Earnings Flash (PRPH) PROPHASE LABS Posts Q3 Revenue $8.4M
09/11
MT
ProPhase Labs, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
09/11
CI
ProPhase Labs, Inc.'s Equity Buyback announced on March 15, 2023, has expired with 69,628 shares, representing 0.43% for $0.59 million.
15/23/15
CI
Tranche Update on ProPhase Labs, Inc.'s Equity Buyback Plan announced on March 15, 2023.
12/23/12
CI
Transcript : ProPhase Labs, Inc., Q2 2023 Earnings Call, Aug 10, 2023
10/23/10
Earnings Flash (PRPH) PROPHASE LABS Reports Q2 Revenue $13.2M
10/23/10
MT
ProPhase Labs, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
10/23/10
CI
Navidea Biopharmaceuticals Confirms Rejection of ProPhase Labs' Proposal to Buy Some of Its Assets
30/23/30
MT
ProPhase Labs Says Offer to Acquire Certain Navidea Biopharmaceuticals' Assets Rejected
29/23/29
MT
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
ProPhase Labs, Inc. is a biopharma, genomics, and diagnostics company. The Company provides whole genome sequencing solutions, while developing potential diagnostics and therapeutics in the fight against cancer. This includes a potentially life-saving cancer test focused on early detection of esophageal cancer and potential breakthrough cancer therapeutics with novel mechanisms of action. Its segments include diagnostic services and consumer products. The diagnostic services segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third party payers and government organizations. The consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of over-the-counter consumer healthcare products and dietary supplements in the United States and also provides personal genomics products and services. Its CLIA labs and diagnostic technology provide wellness solutions.
More about the company
Last Close Price
5.05
USD
Average target price
18.5
USD
Spread / Average Target
+266.34%
Consensus
1st Jan change
Capi.
+11.73% 96.35M -23.07% 7.86B +68.36% 4.32B +1.88% 2.63B -8.06% 2.5B -41.95% 2.33B -11.99% 1.82B -21.18% 1.51B +17.44% 1.22B -43.89% 1.14B
Medical & Diagnostic Laboratories
+951% of historical performance
More than 20 years at your side
Our Experts are here for you
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1